{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:06:36Z","timestamp":1788260796572,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11605-021-05143-6","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T16:08:28Z","timestamp":1632154108000},"page":"398-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prospective Randomized Controlled Trial Comparing Adjuvant Chemotherapy vs. No Chemotherapy for Patients with Carcinoma of Gallbladder Undergoing Curative Resection"],"prefix":"10.1016","volume":"26","author":[{"given":"Sundeep Singh","family":"Saluja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phani Kumar","family":"Nekarakanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurita","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s11605-021-05143-6_bb0010","doi-asserted-by":"crossref","unstructured":"Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008 Dec 1;98(7):485\u20139.","DOI":"10.1002\/jso.21141"},{"key":"10.1007\/s11605-021-05143-6_bb0015","doi-asserted-by":"crossref","unstructured":"Stein A, Arnold D, Bridgewater J, Goldstein D, Jensen LH, Kl\u00fcmpen H-J, et al. Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial. BMC Cancer. 2015 Jul 31;15:564.","DOI":"10.1186\/s12885-015-1498-0"},{"key":"10.1007\/s11605-021-05143-6_bb0020","doi-asserted-by":"crossref","unstructured":"Kattepur AK, Patkar S, Goel M, Ramaswamy A, Ostwal V. Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer. J Gastrointest Surg. 2019 Nov;23(11):2232\u20138.","DOI":"10.1007\/s11605-019-04104-4"},{"key":"10.1007\/s11605-021-05143-6_bb0025","doi-asserted-by":"crossref","unstructured":"Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003 Mar;4(3):167\u201376.","DOI":"10.1016\/S1470-2045(03)01021-0"},{"key":"10.1007\/s11605-021-05143-6_bb0030","doi-asserted-by":"crossref","unstructured":"Choudhary S, Asthana AK. Impact of Adjuvant Therapy on Survival in Curatively Resected Gallbladder Carcinoma. J Clin Diagn Res. 2015 Sep;9(9):XC01\u20134.","DOI":"10.7860\/JCDR\/2015\/15113.6436"},{"issue":"3","key":"10.1007\/s11605-021-05143-6_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s005340050044","article-title":"A new in-vitro drug sensitivity test (collagen-gel droplet embedded-culture drug sensitivity test) in carcinomas of pancreas and biliary tract: possible clinical utility","volume":"5","author":"Yasuda","year":"1998","journal-title":"J Hepatobiliary Pancreat Surg."},{"key":"10.1007\/s11605-021-05143-6_bb0040","doi-asserted-by":"crossref","unstructured":"Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002 Oct 15;95(8):1685\u201395.","DOI":"10.1002\/cncr.10831"},{"key":"10.1007\/s11605-021-05143-6_bb0045","doi-asserted-by":"crossref","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010 Apr 8;362(14):1273\u201381.","DOI":"10.1056\/NEJMoa0908721"},{"key":"10.1007\/s11605-021-05143-6_bb0050","doi-asserted-by":"crossref","unstructured":"Valle JW, Wasan H, Johnson P, Jones E, Dixon L, Swindell R, et al. Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study \u2013 The UK ABC-01 Study. Br J Cancer. 2009 Aug 18;101(4):621\u20137.","DOI":"10.1038\/sj.bjc.6605211"},{"key":"10.1007\/s11605-021-05143-6_bb0055","doi-asserted-by":"crossref","unstructured":"Okusaka T, Nakachi K, Fukutomi A, Mizuno N, Ohkawa S, Funakoshi A, et al. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer. 2010 Aug 10;103(4):469\u201374.","DOI":"10.1038\/sj.bjc.6605779"},{"key":"10.1007\/s11605-021-05143-6_bb0060","doi-asserted-by":"crossref","unstructured":"Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012 Jun 1;30(16):1934\u201340.","DOI":"10.1200\/JCO.2011.40.5381"},{"key":"10.1007\/s11605-021-05143-6_bb0065","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) [Internet]. 2017. Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference:5x7.pdf"},{"key":"10.1007\/s11605-021-05143-6_bb0070","doi-asserted-by":"crossref","unstructured":"Edeline J, Benabdelghani M, Bertaut A, Watelet J, Hammel P, Joly J-P, et al. Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study. J Clin Oncol. 2019 Mar 10;37(8):658\u201367.","DOI":"10.1200\/JCO.18.00050"},{"key":"10.1007\/s11605-021-05143-6_bb0075","unstructured":"Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019 May;20(5):663\u201373."},{"key":"10.1007\/s11605-021-05143-6_bb0080","doi-asserted-by":"crossref","unstructured":"Ben-Josef E, Guthrie KA, El-Khoueiry AB, Corless CL, Zalupski MM, Lowy AM, et al. SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma. J Clin Oncol. 2015 Aug 20;33(24):2617\u201322.","DOI":"10.1200\/JCO.2014.60.2219"},{"key":"10.1007\/s11605-021-05143-6_bb0085","doi-asserted-by":"crossref","unstructured":"Bergquist JR, Shah HN, Habermann EB, Hernandez MC, Ivanics T, Kendrick ML, et al. Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study). Int J Surg. 2018 Apr;52:171\u20139.","DOI":"10.1016\/j.ijsu.2018.02.052"},{"key":"10.1007\/s11605-021-05143-6_bb0090","doi-asserted-by":"crossref","unstructured":"Ma N, Cheng H, Qin B, Zhong R, Wang B. Adjuvant therapy in the treatment of gallbladder cancer: a meta-analysis. BMC Cancer. 2015 Sep 3;15(1):615.","DOI":"10.1186\/s12885-015-1617-y"},{"key":"10.1007\/s11605-021-05143-6_bb0095","doi-asserted-by":"crossref","unstructured":"Manterola C, Duque G, Grande L, Aretxabala X de, Conejeros R, Otzen T, et al. A systematic review of the effectiveness of adjuvant therapy for patients with gallbladder cancer. HPB. 2019 Nov 1;21(11):1427\u201335.","DOI":"10.1016\/j.hpb.2019.02.019"},{"key":"10.1007\/s11605-021-05143-6_bb0100","doi-asserted-by":"crossref","unstructured":"Tran Cao HS, Zhang Q, Sada YH, Chai C, Curley SA, Massarweh NN. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts. Cancer. 2018 Jan 1;124(1):74\u201383.","DOI":"10.1002\/cncr.30968"},{"key":"10.1007\/s11605-021-05143-6_bb0105","doi-asserted-by":"crossref","unstructured":"Go S-I, Kim YS, Hwang IG, Kim EY, Oh SY, Ji JH, et al. Is There a Role for Adjuvant Therapy in R0 Resected Gallbladder Cancer?: A Propensity Score-Matched Analysis. Cancer Res Treat. 2016 Oct;48(4):1274\u201385.","DOI":"10.4143\/crt.2015.502"},{"key":"10.1007\/s11605-021-05143-6_bb0110","doi-asserted-by":"crossref","unstructured":"Chen C, Feng W, Zheng Y, Bao Y, Feng M. Intra-arterial chemotherapy improved survival of stage 2\u20133 gallbladder cancer after curative resection. Onco Targets Ther. 2018 May 22;11:2975\u20139.","DOI":"10.2147\/OTT.S166246"},{"key":"10.1007\/s11605-021-05143-6_bb0115","doi-asserted-by":"crossref","unstructured":"Kasumova GG, Tabatabaie O, Najarian RM, Callery MP, Ng SC, Bullock AJ, et al. Surgical Management of Gallbladder Cancer: Simple Versus Extended Cholecystectomy and the Role of Adjuvant Therapy. Ann Surg. 2017 Oct;266(4):625\u201331.","DOI":"10.1097\/SLA.0000000000002385"},{"key":"10.1007\/s11605-021-05143-6_bb0120","doi-asserted-by":"crossref","unstructured":"Kim TG. Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy. Radiat Oncol J. 2017 Dec;35(4):359\u201367.","DOI":"10.3857\/roj.2017.00388"},{"key":"10.1007\/s11605-021-05143-6_bb0125","unstructured":"Nakamura M, Nakashima H, Abe T, Ensako T, Yoshida K, Hino K. Gemcitabine-based adjuvant chemotherapy for patients with advanced gallbladder cancer. Anticancer Res. 2014 Jun;34(6):3125\u20139."},{"key":"10.1007\/s11605-021-05143-6_bb0130","unstructured":"ECOG-ACRIN Cancer Research Group. Optimal Perioperative Therapy for Incidental Gallbladder Cancer (OPT-IN): A Randomized Phase II\/III Trial [Internet]. clinicaltrials.gov; 2020 Dec [cited 2021 Feb 11]. Report No.: NCT04559139. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04559139"},{"key":"10.1007\/s11605-021-05143-6_bb0135","doi-asserted-by":"crossref","unstructured":"Sharma A, Shukla NK, Chaudhary SP, Sahoo R, Mohanti B, Deo SVS, et al. Final results of a phase III randomized controlled trial comparing modified gemcitabine + oxaliplatin (mGEMOX) to gemcitabine+ cisplatin in management of unresectable gall bladder cancer (GBC). JCO. 2016 May 20;34(15_suppl):4077\u20134077.","DOI":"10.1200\/JCO.2016.34.15_suppl.4077"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-021-05143-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11605-021-05143-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23003098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23003098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-021-05143-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:06:29Z","timestamp":1761077189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23003098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1091255X23003098"],"URL":"https:\/\/doi.org\/10.1007\/s11605-021-05143-6","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective Randomized Controlled Trial Comparing Adjuvant Chemotherapy vs. No Chemotherapy for Patients with Carcinoma of Gallbladder Undergoing Curative Resection","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-021-05143-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}